Skip to main navigation
Skip to search
Skip to main content
Chang Gung University Academic Capacity Ensemble Home
Help & FAQ
English
中文
Home
Profiles
Research units
Research output
Projects
Equipment
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
EXAMINE Investigators
University of Connecticut
Brigham and Women’s Hospital
University of Sheffield
Cleveland Clinic Foundation
Park Nicollet Health Services
The University of Chicago
Takeda Development Center Americas, Inc.
Harvard University
University of Tennessee Health Science Center
Université de Lorraine
Unknown
Research output
:
Contribution to journal
›
Journal Article
›
peer-review
2254
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Alogliptin after acute coronary syndrome in patients with type 2 diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Acute Coronary Syndrome
100%
Acute Heart Infarction
14%
Amaurosis
14%
Antidiabetic Agent
14%
Apoplexy
14%
Cardiovascular Agent
14%
Cardiovascular Disease
14%
Cardiovascular Risk
14%
Cardiovascular System
42%
Chemotherapeutic Agent
14%
Combination Therapy
14%
Death
14%
Dipeptidyl Peptidase IV
14%
Dipeptidyl Peptidase-4 Inhibitor
14%
Drug
14%
Drug Therapy
14%
Evaluation Study
14%
Glycated Hemoglobin
14%
Hazard Ratio
28%
Hypoglycemia
14%
Incidence
14%
Inpatient
100%
Malignant Neoplasm
14%
Myocardial Infarction
14%
Noninferiority Trial
14%
Pancreatitis
14%
Patient
42%
Patient with Type 2 Diabetes
100%
Placebo
85%
Study Design
14%
Unstable Angina Pectoris
14%